Welcome to CSNpharm! For Research Use Only!
DPP4
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN19749 | ZY15557 | 1601480-12-9 | ZY15557 is a potent competitive and long acting DPP-4 inhibitor showing similar DPP-4 inhibition across different species |
| CSN12287 | Vildagliptin | 274901-16-5 | Vildagliptin is an inhibitor of DPP-4 with IC50 of 2.3 nM that is used in the treatment of type 2 diabetes mellitus. |
| CSN21260 | Vildagliptin dihydrate | 2133364-01-7 | Vildagliptin (LAF237 dihydrateNVP-LAF 237 dihydrate) is a dipeptidyl peptidase 4 (DPP4) inhibitor that delays the degradation of glucagon-like peptide-1 (GLP-1). |
| CSN16203 | Trelagliptin succinate | 1029877-94-8 | Trelagliptin succinate is an highly selective inhibitor of dipeptidyl peptidase-4 DPP-4 that is used for the treatment of type 2 diabetes |
| CSN16209 | Trelagliptin | 865759-25-7 | Trelagliptin is a long acting dipeptidyl peptidase-4 DPP-4 inhibitor that is being developed for the treatment of type 2 diabetes T2D |
| CSN13813 | Teneligliptin | 760937-92-6 | Teneligliptin is a potent and long-lasting dipeptidyl peptidase-4 inhibitor and competitively inhibits human plasma rat plasma and human recombinant DPP-4 in vitro with IC50 values of approximately 1 nM |
| CSN17332 | Teneligliptin hydrobromide | 906093-29-6 | Teneligliptin Hydrobromide is a DPP4 inhibitor with IC50 value of <1 nM. It is commonly used as an add on treatment when meformin is not achieving the expected glycemic goals. |
| CSN13509 | Talabostat mesylate | 150080-09-4 | Talabostat mesilate is an orally active specific inhibitor of dipeptidyl peptidases with IC50 of 1 nM for DPP4 including tumor-associated fibroblast activation protein |
| CSN21888 | Talabostat | 149682-77-9 | Talabostat (Val-boroPro) is an orally active and nonselective dipeptidyl peptidase IV (DPP-IV) inhibitor with IC50 < 4 nM and the first clinical inhibitor of fibroblast activation protein (FAP) with IC50 of 560 nM) and also inhibits DPP8/9 (IC50 = 4/11 nM). |
| CSN10172 | Sitagliptin phosphate monohydrate | 654671-77-9 | Sitagliptin Phosphate Monohydrate is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts |
| CSN12755 | Sitagliptin phosphate | 654671-78-0 | Sitagliptin phosphate is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts |
| CSN17002 | Sitagliptin | 486460-32-6 | Sitagliptin is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts |
| CSN24704 | Saxagliptin hydrochloride | 709031-78-7 | Saxagliptin, also known as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus. . |
| CSN13800 | Saxagliptin hydrate | 945667-22-1 | Saxagliptin the monohydrate form of anhydrous saxagliptin is a reversible and selective DPP4 inhibitor with IC50 of 26 nM It is used for the treatment of type 2 diabetes |
| CSN12346 | Saxagliptin | 361442-04-8 | Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM |
| CSN20590 | Retagliptin phosphate | 1256756-88-3 | Retagliptin phosphate is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes |
| CSN20588 | Retagliptin | 1174122-54-3 | Retagliptin is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes |
| CSN20589 | Retagliptin HCl | 1174038-86-8 | Retagliptin HCl is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes. |
| CSN13845 | Omarigliptin | 1226781-44-7 | Omarigliptin also called MA-3102 is an selective inhibitor of DPP-4 with IC50 of 16 nM and Ki of 08 nM Its selectivity is higher than other 168 proteasomes |
| CSN25709 | NVP-DPP728 dihydrochloride | 207556-62-5 | NVP DPP 728 dihydrochloride is active dipeptidyl peptidase (DPP)-IV inhibitor with Ki and IC50 of 11 nM, 14 nM respectively. |
| CSN22003 | Gosogliptin | 869490-23-3 | Metabolic Disease |
| CSN12323 | Linagliptin | 668270-12-0 | Linagliptin a purine and quinazoline derivative can inhibit DPP-4 with IC50 of 1 nM It functions as an incretin and is used as a hypoglycemic agents in the treatment of type 2 diabetes mellitus |
| CSN20422 | Gemigliptin | 911637-19-9 | Gemigliptin is an oral anti-hyperglycemic agent anti-diabetic drug of the dipeptidyl peptidase-4 DPP-4 inhibitor class of drugs |
| CSN20545 | Evogliptin tartrate | 1222102-51-3 | Evogliptin tartrate is a potent and selective DPP4 inhibitor dipeptidyl peptidase 4 inhibitor which improves insulin resistance and delays the onset of diabetes |
| CSN20543 | Evogliptin | 1222102-29-5 | Evogliptin is a potent and selective DPP4 inhibitor dipeptidyl peptidase 4 inhibitor which improves insulin resistance and delays the onset of diabetes |
| CSN26633 | Dutogliptin tartrate | 890402-81-0 | Dutogliptin, also known as PHX1149, is a selective and orally active DPP4 inhibitor. Dutogliptin improves glycaemic control in patients with type 2 diabetes. PP-4 inhibitors or gliptins, are a class of oral hypoglycemics that block DPP-4. They can be used to treat diabetes mellitus type 2. The first agent of the class - sitagliptin - was approved by the FDA in 2006. |
| CSN25707 | Diprotin A | 90614-48-5 | Diprotin A is the inhibitor of dipeptidyl peptidase IV. It can inhibit entry of HIV-1 or HIV-2 into T lymphoblastoid and monocytoid cell lines. |
| CSN17532 | DBPR108 | 1186426-66-3 | DBPR108 is a potent selective and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM showing no inhibition on DDP8 and DPP9 |
| CSN25468 | Saxagliptin impurity F | 361442-00-4 | Boc-3-hydroxy-1-adamantyl-D-glycine is used in the preparation of a Saxagliptin intermediate. |
| CSN16158 | Anagliptin | 739366-20-2 | Anagliptin is a potent and selective DPP-4 inhibitorIC50 38 nM and 10 fold less potent for DPP-8 and DPP-9 |
| CSN10251 | Alogliptin | 850649-61-5 | Alogliptin is a dipeptidyl peptidase 4 DPP-4 inhibitor with IC50 of 69 nM that exhibits greater selective than DPP-2 DPP-8 and DPP-9 |
| CSN12318 | Alogliptin Benzoate | 850649-62-6 | Alogliptin benzoate is the benzoate salt form of alogliptin which is a selective inhibitor of DPP-4 with IC50 of 69 nM that exhibits greater selective than DPP-2 DPP-8 and DPP-9 |
| CSN13542 | 5-O-Demethylnobiletin | 2174-59-6 | 5-O-Demethylnobiletin, a flavonoid isolated from the peel of Citrus nobilis Lour., shows a certain inhibitory effect on DPP-IV enzyme. |
| CSN25467 | (2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetic acid | 709031-29-8 | 3-Hydroxy-1-adamantyl-D-glycine is a non-proteinogenic amino acid , which is a key intermediate required for the synthesis of Saxagliptin (S143500). |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
